Target Gene/Pathway PATHWAY / GENE


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Acute myeloid leukemia 💬
1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
2 Acute myeloid leukemia 💬
4件: BRAF, FLT3, KIT, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
3 Acute myeloid leukemia 💬
4件: BRAF, FLT3, KIT, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
4 Acute myeloid leukemia 💬
3件: CSF1R, FLT3, KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
5 Acute myeloid leukemia 💬
2件: FLT3, KIT 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
6 Acute myeloid leukemia 💬
2件: FLT3, KIT 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
7 Acute myeloid leukemia 💬
1件: KIT 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
8 Acute myeloid leukemia 💬
1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
9 Acute myeloid leukemia 💬
1件: KIT 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
10 Acute myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
11 Acute myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
12 Acute myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
13 Acute myeloid leukemia 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
14 Acute myeloid leukemia 💬
1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
15 Acute myeloid leukemia 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
16 Adherens junction 💬
1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
17 Adherens junction 💬
1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
18 Adherens junction 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
19 Adherens junction 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
20 Adherens junction 💬
1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
21 Adipocytokine signaling pathway 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
22 Adipocytokine signaling pathway 💬
1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
23 Adipocytokine signaling pathway 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
24 Adipocytokine signaling pathway 💬
1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
25 Adipocytokine signaling pathway 💬
1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
26 Adipocytokine signaling pathway 💬
1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
27 Adrenergic signaling in cardiomyocytes 💬
1件: SCN5A 💬 D00354 💬 Lamotrigine 5件: 13, 34, 38, 114, 144 💬
28 Adrenergic signaling in cardiomyocytes 💬
1件: SCN5A 💬 D00358 💬 Lidocaine 13件:  6 , 13, 34, 46, 51, 70, 84, 86, 107, 168, 226, 231, 256 💬
29 Adrenergic signaling in cardiomyocytes 💬
1件: SCN5A 💬 D02086 💬 Lidocaine 13件:  6 , 13, 34, 46, 51, 70, 84, 86, 107, 168, 226, 231, 256 💬
30 Adrenergic signaling in cardiomyocytes 💬
1件: SCN5A 💬 D08127 💬 Lidocaine 13件:  6 , 13, 34, 46, 51, 70, 84, 86, 107, 168, 226, 231, 256 💬
31 African trypanosomiasis 💬
4件: IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
32 African trypanosomiasis 💬
2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
33 African trypanosomiasis 💬
1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
34 AGE-RAGE signaling pathway in diabetic complications 💬
5件: CCL2, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
35 AGE-RAGE signaling pathway in diabetic complications 💬
1件: CDK4 💬 D10688 💬 Abemaciclib 1件: 34 💬
36 AGE-RAGE signaling pathway in diabetic complications 💬
2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
37 AGE-RAGE signaling pathway in diabetic complications 💬
1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
38 AGE-RAGE signaling pathway in diabetic complications 💬
1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
39 AGE-RAGE signaling pathway in diabetic complications 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
40 Alanine, aspartate and glutamate metabolism 💬
4件: ABAT, ALDH5A1, GAD1, GAD2 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
41 Alcoholic liver disease 💬
3件: IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
42 Alcoholic liver disease 💬
2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
43 Alcoholic liver disease 💬
1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
44 Alcoholism 💬
1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
45 Alcoholism 💬
2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
46 Alcoholism 💬
2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
47 Alcoholism 💬
1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
48 Alcoholism 💬
1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
49 Alcoholism 💬
1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
50 Alcoholism 💬
1件: SLC6A3 💬 D01296 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
51 Alcoholism 💬
1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
52 Aldosterone synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
53 Allograft rejection 💬
2件: IL10, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
54 Allograft rejection 💬
1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
55 Allograft rejection 💬
1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
56 Alzheimer disease 💬
1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
57 Alzheimer disease 💬
2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
58 Alzheimer disease 💬
2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
59 Alzheimer disease 💬
1件: CSF1 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
60 Alzheimer disease 💬
1件: CSF1 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
61 Alzheimer disease 💬
4件: IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
62 Alzheimer disease 💬
2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
63 Alzheimer disease 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
64 Alzheimer disease 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
65 Alzheimer disease 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
66 Alzheimer disease 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
67 Alzheimer disease 💬
1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
68 Alzheimer disease 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
69 Alzheimer disease 💬
1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
70 Alzheimer disease 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
71 Alzheimer disease 💬
1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
72 Alzheimer disease 💬
1件: PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
73 Alzheimer disease 💬
1件: PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
74 Alzheimer disease 💬
1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
75 Alzheimer disease 💬
1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
76 Alzheimer disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D01068 💬 Vinblastine 2件: 34, 65 💬
77 Alzheimer disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 2件: 34, 65 💬
78 Alzheimer disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 4件: 26, 34, 65, 331 💬
79 Alzheimer disease 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 4件: 26, 34, 65, 331 💬
80 Amoebiasis 💬
4件: IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
81 Amoebiasis 💬
2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
82 Amoebiasis 💬
1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
83 Amphetamine addiction 💬
1件: SLC6A3 💬 D01296 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
84 Amphetamine addiction 💬
1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
85 AMPK signaling pathway 💬
1件: HMGCR 💬 D00359 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
86 AMPK signaling pathway 💬
1件: HMGCR 💬 D00434 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
87 AMPK signaling pathway 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
88 AMPK signaling pathway 💬
1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
89 AMPK signaling pathway 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
90 Amyotrophic lateral sclerosis 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
91 Amyotrophic lateral sclerosis 💬
1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
92 Amyotrophic lateral sclerosis 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
93 Amyotrophic lateral sclerosis 💬
1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
94 Amyotrophic lateral sclerosis 💬
1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
95 Amyotrophic lateral sclerosis 💬
1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
96 Amyotrophic lateral sclerosis 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D01068 💬 Vinblastine 2件: 34, 65 💬
97 Amyotrophic lateral sclerosis 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08675 💬 Vinblastine 2件: 34, 65 💬
98 Amyotrophic lateral sclerosis 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D02197 💬 Vincristine 4件: 26, 34, 65, 331 💬
99 Amyotrophic lateral sclerosis 💬
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 D08679 💬 Vincristine 4件: 26, 34, 65, 331 💬
100 Antifolate resistance 💬
2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
101 Antifolate resistance 💬
2件: DHFR, DHFR2 💬 D02115 💬 Methotrexate 38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
102 Antifolate resistance 💬
3件: IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
103 Antifolate resistance 💬
2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
104 Antifolate resistance 💬
1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
105 Antigen processing and presentation 💬
1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
106 Antigen processing and presentation 💬
1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
107 Antigen processing and presentation 💬
1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
108 Apelin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
109 Apelin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
110 Apelin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
111 Apelin signaling pathway 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
112 Apelin signaling pathway 💬
1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
113 Apelin signaling pathway 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
114 Apelin signaling pathway 💬
1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
115 Apelin signaling pathway 💬
1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
116 Apoptosis 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
117 Apoptosis 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
118 Apoptosis 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
119 Apoptosis 💬
1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
120 Apoptosis 💬
1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
121 Apoptosis 💬
1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
122 Apoptosis 💬
1件: TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
123 Apoptosis 💬
1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
124 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
125 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
126 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
127 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
128 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
129 Arachidonic acid metabolism 💬
1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
130 Asthma 💬
2件: IL10, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
131 Asthma 💬
1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
132 Asthma 💬
1件: TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
133 Autoimmune thyroid disease 💬
1件: IL10 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
134 Autophagy - animal 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
135 Autophagy - animal 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
136 Autophagy - animal 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
137 Autophagy - animal 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
138 Autophagy - animal 💬
1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
139 Autophagy - animal 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
140 Autophagy - animal 💬
1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
141 Autophagy - animal 💬
1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
142 Autophagy - other 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
143 Autophagy - other 💬
1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
144 Autophagy - other 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
145 Axon guidance 💬
1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
146 Axon guidance 💬
1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
147 Axon guidance 💬
1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
148 Axon guidance 💬
1件: BMPR2 💬 D03779 💬 Dibotermin alfa 1件: 34 💬
149 Axon guidance 💬
1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
150 Axon guidance 💬
1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
151 Axon guidance 💬
1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
152 B cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
153 B cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
154 B cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
155 B cell receptor signaling pathway 💬
1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
156 B cell receptor signaling pathway 💬
1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
157 Bacterial invasion of epithelial cells 💬
1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
158 beta-Alanine metabolism 💬
3件: ABAT, GAD1, GAD2 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
159 Bile secretion 💬
1件: HMGCR 💬 D00359 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
160 Bile secretion 💬
1件: HMGCR 💬 D00434 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
161 Biosynthesis of cofactors 💬
2件: DHFR, DHFR2 💬 D00142 💬 Methotrexate 38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
162 Biosynthesis of cofactors 💬
2件: DHFR, DHFR2 💬 D02115 💬 Methotrexate 38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
163 Bladder cancer 💬
1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
164 Bladder cancer 💬
2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
165 Bladder cancer 💬
2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
166 Bladder cancer 💬
1件: CDK4 💬 D10688 💬 Abemaciclib 1件: 34 💬
167 Bladder cancer 💬
1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
168 Bladder cancer 💬
1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
169 Bladder cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
170 Bladder cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
171 Bladder cancer 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
172 Bladder cancer 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
173 Bladder cancer 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
174 Bladder cancer 💬
1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
175 Bladder cancer 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
176 Breast cancer 💬
1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
177 Breast cancer 💬
4件: BRAF, FLT4, KIT, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
178 Breast cancer 💬
4件: BRAF, FLT4, KIT, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
179 Breast cancer 💬
2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
180 Breast cancer 💬
1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
181 Breast cancer 💬
1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
182 Breast cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
183 Breast cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
184 Breast cancer 💬
1件: FLT4 💬 D03218 💬 Axitinib 1件: 34 💬
185 Breast cancer 💬
1件: FLT4 💬 D08881 💬 Cediranib 1件: 34 💬
186 Breast cancer 💬
2件: FLT4, KIT 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
187 Breast cancer 💬
2件: FLT4, KIT 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
188 Breast cancer 💬
1件: KIT 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
189 Breast cancer 💬
1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
190 Breast cancer 💬
1件: KIT 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
191 Breast cancer 💬
1件: KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
192 Breast cancer 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
193 Breast cancer 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
194 Breast cancer 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
195 Breast cancer 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
196 Breast cancer 💬
1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
197 Breast cancer 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
198 Butanoate metabolism 💬
4件: ABAT, ALDH5A1, GAD1, GAD2 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
199 C-type lectin receptor signaling pathway 💬
4件: IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
200 C-type lectin receptor signaling pathway 💬
2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
201 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
202 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
203 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
204 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
205 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
206 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
207 C-type lectin receptor signaling pathway 💬
1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
208 C-type lectin receptor signaling pathway 💬
1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
209 C-type lectin receptor signaling pathway 💬
1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
210 Calcium signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
211 Calcium signaling pathway 💬
1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
212 Calcium signaling pathway 💬
1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
213 Calcium signaling pathway 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
214 Calcium signaling pathway 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
215 Calcium signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 D03218 💬 Axitinib 1件: 34 💬
216 Calcium signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 D08881 💬 Cediranib 1件: 34 💬
217 Calcium signaling pathway 💬
6件: FLT1, FLT4, KDR, PDGFRA, PDGFRB, RET 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
218 Calcium signaling pathway 💬
6件: FLT1, FLT4, KDR, PDGFRA, PDGFRB, RET 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
219 Calcium signaling pathway 💬
4件: FLT4, KDR, PDGFRB, RET 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
220 Calcium signaling pathway 💬
4件: FLT4, KDR, PDGFRB, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
221 Calcium signaling pathway 💬
2件: KDR, MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
222 Calcium signaling pathway 💬
1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
223 Calcium signaling pathway 💬
1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
224 Calcium signaling pathway 💬
2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
225 Calcium signaling pathway 💬
1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
226 Calcium signaling pathway 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
227 cAMP signaling pathway 💬
1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
228 cAMP signaling pathway 💬
2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
229 cAMP signaling pathway 💬
2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
230 cAMP signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
231 cAMP signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
232 cAMP signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
233 Cell cycle 💬
1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
234 Cell cycle 💬
1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
235 Cell cycle 💬
1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
236 Cell cycle 💬
2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
237 Cellular senescence 💬
2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
238 Cellular senescence 💬
2件: IL1A, IL6 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
239 Cellular senescence 💬
1件: IL6 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
240 Cellular senescence 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
241 Cellular senescence 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
242 Cellular senescence 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
243 Cellular senescence 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
244 Cellular senescence 💬
1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
245 Cellular senescence 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
246 Cellular senescence 💬
1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
247 Cellular senescence 💬
1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
248 Central carbon metabolism in cancer 💬
1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
249 Central carbon metabolism in cancer 💬
1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
250 Central carbon metabolism in cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
251 Central carbon metabolism in cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
252 Central carbon metabolism in cancer 💬
2件: FLT3, KIT 💬 D11270 💬 Pexidartinib 1件: 34 💬
253 Central carbon metabolism in cancer 💬
5件: FLT3, KIT, PDGFRA, PDGFRB, RET 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
254 Central carbon metabolism in cancer 💬
5件: FLT3, KIT, PDGFRA, PDGFRB, RET 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
255 Central carbon metabolism in cancer 💬
5件: FLT3, KIT, PDGFRB, RAF1, RET 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
256 Central carbon metabolism in cancer 💬
5件: FLT3, KIT, PDGFRB, RAF1, RET 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
257 Central carbon metabolism in cancer 💬
2件: KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
258 Central carbon metabolism in cancer 💬
2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
259 Central carbon metabolism in cancer 💬
3件: KIT, PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
260 Central carbon metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
261 Central carbon metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
262 Central carbon metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
263 Central carbon metabolism in cancer 💬
1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
264 Central carbon metabolism in cancer 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
265 Central carbon metabolism in cancer 💬
1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
266 Central carbon metabolism in cancer 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
267 cGMP-PKG signaling pathway 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 D00514 💬 Dexmedetomidine 13件:  2 ,  4 ,  6 , 21, 34, 46, 70, 107, 113, 212, 215, 226, 280 💬
268 cGMP-PKG signaling pathway 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 D01205 💬 Dexmedetomidine 13件:  2 ,  4 ,  6 , 21, 34, 46, 70, 107, 113, 212, 215, 226, 280 💬
269 cGMP-PKG signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
270 cGMP-PKG signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
271 cGMP-PKG signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
272 cGMP-PKG signaling pathway 💬
1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
273 cGMP-PKG signaling pathway 💬
1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
274 Chagas disease 💬
5件: CCL2, IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
275 Chagas disease 💬
2件: IL6, TNF 💬 D08976 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
276 Chagas disease 💬
1件: TNF 💬 D04687 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
277 Chemical carcinogenesis - DNA adducts 💬
1件: PTGS2 💬 D00217 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 💬
278 Chemical carcinogenesis - DNA adducts 💬
1件: PTGS2 💬 D00109 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 58, 86, 96, 97, 113, 158, 210, 231, 251 💬
279 Chemical carcinogenesis - DNA adducts 💬
1件: PTGS2 💬 D00567 💬 Celecoxib 10件:  2 ,  3 , 34, 46, 70, 89, 107, 161, 171, 271 💬
280 Chemical carcinogenesis - DNA adducts 💬
1件: PTGS2 💬 D00903 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
281 Chemical carcinogenesis - DNA adducts 💬
1件: PTGS2 💬 D00904 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
282 Chemical carcinogenesis - DNA adducts 💬
1件: PTGS2 💬 D07816 💬 Diclofenac 5件: 13, 34, 46, 78, 271 💬
283 Chemical carcinogenesis - reactive oxygen species 💬
1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
284 Chemical carcinogenesis - reactive oxygen species 💬
1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
285 Chemical carcinogenesis - reactive oxygen species 💬
1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
286 Chemical carcinogenesis - reactive oxygen species 💬
1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
287 Chemical carcinogenesis - reactive oxygen species 💬
2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
288 Chemical carcinogenesis - reactive oxygen species 💬
2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
289 Chemical carcinogenesis - reactive oxygen species 💬
1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
290 Chemical carcinogenesis - reactive oxygen species 💬
1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
291 Chemical carcinogenesis - reactive oxygen species 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
292 Chemical carcinogenesis - reactive oxygen species 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
293 Chemical carcinogenesis - reactive oxygen species 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
294 Chemical carcinogenesis - reactive oxygen species 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
295 Chemical carcinogenesis - reactive oxygen species 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
296 Chemical carcinogenesis - reactive oxygen species 💬
1件: MET 💬 D10062 💬 Cabozantinib 1件: 34 💬
297 Chemical carcinogenesis - reactive oxygen species 💬
1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
298 Chemical carcinogenesis - reactive oxygen species 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
299 Chemical carcinogenesis - receptor activation 💬
1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
300 Chemical carcinogenesis - receptor activation 💬
1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
301 Chemical carcinogenesis - receptor activation 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
302 Chemical carcinogenesis - receptor activation 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
303 Chemical carcinogenesis - receptor activation 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
304 Chemical carcinogenesis - receptor activation 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
305 Chemical carcinogenesis - receptor activation 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
306 Chemical carcinogenesis - receptor activation 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
307 Chemical carcinogenesis - receptor activation 💬
1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
308 Chemical carcinogenesis - receptor activation 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
309 Chemical carcinogenesis - receptor activation 💬
1件: RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
310 Chemical carcinogenesis - receptor activation 💬
1件: RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
311 Chemical carcinogenesis - receptor activation 💬
1件: VDR 💬 D00188 💬 Cholecalciferol 25件:  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 75, 84, 85, 96, 97, 98, 162, 202, 228, 271, 298, 299 💬
312 Chemical carcinogenesis - receptor activation 💬
1件: VEGFA 💬 D06409 💬 Bevacizumab 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
313 Chemical carcinogenesis - receptor activation 💬
1件: VEGFA 💬 D05697 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
314 Chemokine signaling pathway 💬
1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
315 Chemokine signaling pathway 💬
2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
316 Chemokine signaling pathway 💬
2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
317 Chemokine signaling pathway 💬
1件: CCL2 💬 D01583 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
318 Chemokine signaling pathway 💬
1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
319 Chemokine signaling pathway 💬
1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
320 Chemokine signaling pathway 💬
1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
321 Choline metabolism in cancer 💬
1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
322 Choline metabolism in cancer 💬
1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
323 Choline metabolism in cancer 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
324 Choline metabolism in cancer 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
325 Choline metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
326 Choline metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
327 Choline metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
328 Choline metabolism in cancer 💬
1件: MTOR 💬 D02714 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
329 Choline metabolism in cancer 💬
1件: MTOR 💬 D00753 💬 Sirolimus 41件:  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
330 Choline metabolism in cancer 💬
1件: MTOR 💬 D06068 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
331 Choline metabolism in cancer 💬
1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
332 Choline metabolism in cancer 💬
1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
333 Choline metabolism in cancer 💬
2件: PDGFRA, PDGFRB 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
334 Choline metabolism in cancer 💬
2件: PDGFRA, PDGFRB 💬 D06402 💬 Sunitinib 2件: 28, 34 💬
335 Choline metabolism in cancer 💬
2件: PDGFRA, PDGFRB 💬 D08552 💬 Sunitinib 2件: 28, 34 💬
336 Choline metabolism in cancer 💬
2件: PDGFRB, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
337 Choline metabolism in cancer 💬
2件: PDGFRB, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
338 Cholinergic synapse 💬
1件: MAP2K1 💬 D10604 💬 Binimetinib 1件: 34 💬
339 Cholinergic synapse 💬
1件: MAP2K1 💬 D09666 💬 Selumetinib 1件: 34 💬
340 Cholinergic synapse 💬
1件: MAP2K1 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
341 Chronic myeloid leukemia 💬
1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
342 Chronic myeloid leukemia 💬
1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
343 Chronic myeloid leukemia 💬
1件: ABL1 💬 D08953 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
344 Chronic myeloid leukemia 💬
1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
345 Chronic myeloid leukemia 💬
2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
346 Chronic myeloid leukemia 💬
2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
347 Chronic myeloid leukemia 💬
2件: CDK4, CDK6 💬 D10688 💬 Abemaciclib 1件: 34 💬
348 Chronic myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
349 Chronic myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 D09666 💬 Selumetinib 1件: 34 💬
350 Chronic myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 D10175 💬 Trametinib 4件:  2 , 34, 279, 280 💬
351 Circadian entrainment 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
352 Cocaine addiction 💬
1件: SLC6A3 💬 D01296 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
353 Cocaine addiction 💬
1件: SLC6A3 💬 D04999 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
354 Colorectal cancer 💬
1件: BRAF 💬 D10064 💬 Dabrafenib 1件: 34 💬
355 Colorectal cancer 💬
2件: BRAF, RAF1 💬 D06272 💬 Sorafenib 2件: 34, 86 💬
356 Colorectal cancer 💬
2件: BRAF, RAF1 💬 D08524 💬 Sorafenib 2件: 34, 86 💬
357 Colorectal cancer 💬
1件: EGFR 💬 D03455 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
358 Colorectal cancer 💬
1件: EGFR 💬 D11251 💬 Icotinib 1件: 34 💬
359 Colorectal cancer 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
360 Colorectal cancer 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
361 Colorectal cancer 💬
2件: MAP2K1, MAP2K2 💬 D10604 💬 Binimetinib 1件: 34 💬
362